id: underutilization_aud_pharmacotherapy_to_alcohol_associated_liver_disease_mortality
name: Underutilization of Alcohol Use Disorder Pharmacotherapy â†’ Alcohol-Associated
  Liver Disease Mortality
from_node:
  node_id: underutilization_aud_pharmacotherapy
  node_name: Underutilization of Alcohol Use Disorder Pharmacotherapy
to_node:
  node_id: alcohol_associated_liver_disease_mortality
  node_name: Alcohol-Associated Liver Disease Mortality
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Efficacious pharmacological treatments for alcohol use disorder exist but
  are seldomly prescribed to patients who need them'
- 'Step 2: Lack of prescription and access to evidence-based treatments results in
  continued unhealthy alcohol use in patients with existing liver disease'
- 'Step 3: Continued alcohol consumption in patients with alcohol-associated liver
  disease accelerates disease progression and hepatic decompensation'
- 'Step 4: Untreated alcohol use disorder leads to increased rates of liver transplantation
  need and liver-related deaths'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Lamia Y Haque et al. 2024. "Treatment of alcohol use disorder
    in patients with alcohol-associated liver disease: Innovative approaches and a
    call to action." *Addiction Science & Clinical Practice*. https://doi.org/10.1186/s13722-024-00448-8'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.371542'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: presence_liver_cirrhosis
  direction: strengthens
  strength: strong
  description: The presence of liver cirrhosis complicates pharmacological treatment
    choices, potentially further reducing prescription rates and exacerbating the
    treatment gap
